阿米卡星联合抗假单胞菌β-内酰胺类抗菌药物经验性治疗医院获得性肺炎的系统评价.pdf

ABSTRACT Objective： The and ofAmikacin efficacysafety plus for treatmentof with beta．1actamantibiotics patientshospital empirical evaluated． systematically acquiredpneumonia(HAP)were Methods： controlled Amikacinanti。 Randomized plus trials(RCTs)involving antibioticsfor with Pseudomonasbeta．1actam patients empiricaltreating CochraneCentral ofControlled HAPwereretrievedfromthe Register 2012． toNovember 7,2012．11)，MEDLINE(1950 Trials(CENTRAL，Issue 980toNovember2012．1 BiomedicneDatabase 11)，EMBASE(1 1)，China 970to2012．1 National (CBM，1 1)，China Knowledge Scienceand Periodical 1970～2012．1 Database(VlP, 1)，Chinese Technology wasnotlimited 1970-2012．1 andinternetinformation．Retrieval 1)，meeting trialsandevaluatedthe to reviewersselected quality, language．Two data fromthe the relevant studies，with extracting independentlyeligible ofthe different woul